Osteomyelofibrosis

Also known as: Primary myelofibrosis (disorder) / Primary myelofibrosis / Myelofibrosis (disorder) / Primary myelofibrosis (morphologic abnormality) / Myelofibrosis / Myelosis non-leukemic / Agnogenic myeloid metaplasia / Myelosis-non-leukaemic / Myelosis non-leukaemic

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00039Palifermin2Withdrawn1